
Carol Davis
· ProfessorUniversity of Washington · Education
Active 1967–2022
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Carol Davis is a Professor and the Associate Dean for Research and Partnerships at the UW College of Education. Her research focuses on increasing the success of students who exhibit behavior problems in inclusive school settings. She examines effective strategies to address the needs of students with behavioral issues and is particularly interested in developing systems of teacher and student support in public school environments to promote positive behavior among students with challenging behaviors. Her work emphasizes understanding the variables that contribute to the successful implementation of these strategies by classroom teachers, schools, and districts. Davis has a background in special education, holding an Ed.D. and M.Ed. from the University of Houston and a B.A. from Texas A & M University. Her extensive publication record includes research on behavioral assessment, intervention strategies for children with autism and developmental disabilities, and methods to improve social interactions and reduce challenging behaviors. Her contributions aim to enhance educational practices and support systems for students with disabilities, particularly those with high-incidence disabilities and autism spectrum disorders.
Research topics
- Computer Science
- Psychiatry
- Medicine
- Sociology
- Medical education
- Applied psychology
- Psychology
- Clinical psychology
- Psychotherapist
Selected publications
Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum
Transplantation · 2012-12-29 · 143 citations
reviewPregnancy after solid organ transplantation, although considered high risk for maternal, fetal, and neonatal complications, has been quite successful. Tacrolimus pharmacokinetic changes during pregnancy make interpretation of whole blood trough concentrations particularly challenging. There are multiple factors that can increase the fraction of unbound tacrolimus, including but not limited to low albumin concentration and low red blood cell count. The clinical titration of dosage to maintain who…
Drug Metabolism and Disposition · 2013-04-26 · 111 citations
articleOpen accessBMC Nephrology · 2013-01-17 · 95 citations
articleOpen accessBACKGROUND: AKI is common following liver transplantation and is associated with significant morbidity and mortality. Biomarkers of AKI have not been well established in this setting but are needed to help guide patient care and facilitate development of novel therapeutics. METHODS: Serum creatinine, cystatin C, IL-6, and IL-8 and urine IL-18, NGAL, IL-6, and IL-8 were measured before and within 24 hours after liver transplantation in 40 patients. AKI was defined as a ≥50% sustained increase in…
Tacrolimus placental transfer at delivery and neonatal exposure through breast milk
British Journal of Clinical Pharmacology · 2013-03-26 · 81 citations
articleOpen accessAIM(S): The current investigation aims to provide new insights into fetal exposure to tacrolimus in utero by evaluating maternal and umbilical cord blood (venous and arterial), plasma and unbound concentrations at delivery. This study also presents a case report of tacrolimus excretion via breast milk. METHODS: Maternal and umbilical cord (venous and arterial) samples were obtained at delivery from eight solid organ allograft recipients to measure tacrolimus and metabolite bound and unbound conc…
Journal of Bone and Mineral Research · 2012-12-04 · 73 citations
articleOpen accessLong-term therapy with certain drugs, especially cytochrome P450 (P450; CYP)-inducing agents, confers an increased risk of osteomalacia that is attributed to vitamin D deficiency. Human CYP24A1, CYP3A4, and CYP27B1 catalyze the inactivation and activation of vitamin D and have been implicated in the adverse drug response. In this study, the inducibility of these enzymes and monohydroxylation of 25-hydroxyvitamin D3 (25OHD3) were evaluated after exposure to P450-inducing drugs. With human hepatoc…
Recent grants
NIH · $22.1M · 2009
Frequent coauthors
- 51 shared
Charles E. Alpers
- 38 shared
Michelle A. Josephson
- 38 shared
Patricia L. Adams
- 38 shared
Richard Ν. Fine
- 38 shared
Nina Tolkoff-Rubin
- 37 shared
Dianne B. McKay
Scripps Research Institute
- 37 shared
Sheri M. Krams
Stanford University
- 37 shared
Ginny L. Bumgardner
The Ohio State University
Similar researchers at University of Washington
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Carol Davis
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
